FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2017/10/010150 [Registered on: 23/10/2017] Trial Registered Retrospectively
Last Modified On: 13/10/2017
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Ayurveda
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Study of C1 Herbal oil healing properties in skin wounds 
Scientific Title of Study   Controlled Clinical Trial to assess the effectiveness of topical application of C1 herbal oil on superficial external wounds and split thickness skin graft donor sites for surgical wound healing 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Maneesh Singhal 
Designation  Professor 
Affiliation  All India Institute of Medical Sciences 
Address  Room 5014C, 5th Floor, Teaching Block All India Institute of Medical Sciences Ansari Nagar New Delhi
Room 304, Third Floor Jai Prakash Narayan Apex Trauma Centre AIIMS, Raj Nagar New Delhi
South
DELHI
110029
India 
Phone  26594430  
Fax    
Email  drmaneesh@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Maneesh Singhal 
Designation  Professor 
Affiliation  All India Institute of Medical Sciences 
Address  Room 5014C, 5th Floor, Teaching Block All India Institute of Medical Sciences Ansari Nagar New Delhi
Room 304, Third Floor Jai Prakash Narayan Apex Trauma Centre AIIMS, Raj Nagar New Delhi
South
DELHI
110029
India 
Phone  26594430  
Fax    
Email  drmaneesh@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Maneesh Singhal 
Designation  Professor 
Affiliation  All India Institute of Medical Sciences 
Address  Room 5014C, 5th Floor, Teaching Block All India Institute of Medical Sciences Ansari Nagar New Delhi
Room 304, Third Floor Jai Prakash Narayan Apex Trauma Centre AIIMS, Raj Nagar New Delhi
South
DELHI
110029
India 
Phone  26594430  
Fax    
Email  drmaneesh@gmail.com  
 
Source of Monetary or Material Support  
Central Council for Research in Ayurvedic Sciences (CCRAS) Jawahar Lal Nehru Bhartiya Chikitsa Avum Homeopathy Anusandhan Bhavan No.61-65, Institutional Area, Opp. D Block, Janakpuri, New Delhi - 110058 ( India ) Telephone : 91-011-28525862/28525897/28525852 Fax : 91-011-28520748/28525959 (Office of the DG) 
 
Primary Sponsor  
Name  Central Council for Research in Ayurvedic Sciences CCRAS 
Address  Ministry of AYUSH, Government of India 61-65, Institutional area, Opposite D Block, Janakpuri New Delhi 110058 
Type of Sponsor  Government funding agency 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Maneesh Singhal  Jai Prakash Narayan Apex Trauma Centre, AIIMS  Department of Plastic, Reconstructive & Burns Surgery, Room 304, 3rd Floor
South
DELHI 
26594430

drmaneesh@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institute Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Patients having Superficial external wounds and Split thickness skin graft (STSG) donor sites,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  C1 Herbal Oil  C1 herbal oil is applied topically over STSG donor site as a thin layer of dressing in gel form and assessed for healing over next 10 to 21 days. 
Comparator Agent  Paraffin guage  Conventional dressing is applied on STSG donor site and assessed for healing over the next 10 to 21 days 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients with wounds requiring STSG cover 
 
ExclusionCriteria 
Details  1. Known allergy/hypersensitivity to any of the components of the dressing
2. Fracture/DVT of lower extremity
3. A skin disorder that is chronic or currently active
4. Polytrauma patients
5. Wound at the surgical site prior to surgery
6. Neurological deficit at wound site (Hemiplegia etc.)
7. Haemoglobin level < 7.0 g/dl
8. Serum Albumin <3 g/dl
9. Subjects who, in the opinion of investigator, may not complete the study for any reason
10. Hepatic failure, renal failure, coagulopathy, known cases of Diabetes mellitus
11. Immunocompromised patients such as with Acquired immunodeficiency syndrome or receiving systemic immune suppression
12. Patients who have psychiatric disorders or physical disabilities that hinders the study
13. Pregnancy or Lactation
14. Patient has history of poor wound healing, history of smoking/drug/alcohol abuse
15. Poor prognosis patients unlikely to survive the trial period
16. Patients where a reference wound cannot be treated in isolation from other wounds 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1. Time to complete re-epithelisation
2. Incidence of Wound infection
3. Incidence of Adverse Reactions including allergic contact dermatitis 
4 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
1. Dressing Adherence Score
2. Pain during dressing changes
3. Any systemic effects after treatment
Incidence of Blistering 
10 days
2 weeks

6 days 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   31/05/2016 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   Not yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   This study is a controlled, open label two phase clinical trial. Patients of age group between 18 and 60 years of either gender who present with superficial external wounds or raw areas requiring split thickness skin graft (STSG) coverage of at least 2 strips will be enrolled in the study. The study is being conducted at Jai Prakash Narayan Apex Trauma Centre, New Delhi, India. In first phase of the trial, C1 herbal oil will be used on STSG donor sites to assess the healing properties of the oil. The main ingredient of C1 herbal oil is an ayurvedic folklore medicine used for wounds and skin diseases, recommended for wound cleansing and healing purposes in ayurvedic classics. The physicochemical standards for use of this drug have been developed by the CCRAS.This clinical trial of herbal dressings in split thickness skin graft (STSG) donor sites is directed to find and validate the wound healing properties of herbal medicines, as claimed conventionally. if validated, it would go a long way in decreasing healthcare costs besides including herbal medicines in mainstream clinical medicine. 
Close